Stephen Tyring, MD, PhD
Basic profileThe University of Texas Health Science Center
Stephen Tyring is a Dermatology physician affiliated with The University of Texas Health Science Center. OpenAlex indexes 17 publications with 673 citations (h-index 11); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
451 N Texas Ave
Webster, TX 775984927
Telephone
281-333-2288Registry record last updated 14 Nov 2008.
Clinical trials
- Photodynamic Therapy For Onychomycosis
Sponsor: The University of Texas Health Science Center, Houston
- Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients
Sponsor: Center for Clinical Studies, Texas
- Reduction of Postherpetic Neuralgia in Herpes Zoster
Sponsor: Center for Clinical Studies, Texas
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
50 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202550 payments$35,677openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year202542 payments$19,623openpaymentsdata.cms.gov ↗
- Galderma Laboratories, L.P.Program year202528 payments$14,841openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1989–2004 per NIH RePORTER. The latest:
- Genetic Resistance to Oncogenic Human Papillomaviruses
University of Texas Hlth Sci Ctr Houston
FY2004$69,910R03CA030730 - Genetic Resistance to Oncogenic Human Papillomaviruses
University of Texas Medical Br Galveston
FY2003$71,062R03CA030730 - ABT 606 VS ACYCLOVIR FOR TREATMENT OF HERPES ZOSTER
University of Texas Medical Br Galveston
FY2002$279,290M01RR000073
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical progression of a smallpox postvaccination response
Baylor University Medical Center Proceedings
2026 - FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis
Journal of the American Academy of Dermatology
2024 - Vaccines for the prevention of infectious diseases with mucocutaneous manifestations
Dermatologic Therapy
2009
Similar KOLs
Other experts from the same institution or the same specialty.
John Reveille, MD
The University of Texas Health Science Center
Hazim Safi, MD
The University of Texas Health Science Center
Jimmy Espinoza, MD
The University of Texas Health Science Center
Adelaide Hebert, MD
The University of Texas Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”